Abstract:Background: Voxel-based morphometry studies have repeatedly highlighted the presence of distributed gray matter changes in schizophrenia, but to date, it is not clear if clinically useful prognostic information can be gleaned from structural imaging. The suspected association between gray matter volume (GMV) and duration of psychotic illness, antipsychotic exposure, and symptom severity also limits the prognostic utility of morphometry. We address the question of whether morphometric information from patients with drug-naive first-episode psychosis can predict the linear trajectory of symptoms following early antipsychotic intervention using a longitudinal design. Method: Sixty-two first-episode, drug-naive patients with schizophrenia underwent brain magnetic resonance imaging scans at baseline, treated with antipsychotics, and rescanned after 1-year follow-up. Positive and Negative Syndrome Scale (PANSS) was used to assess their clinical manifestations. A multivariate approach to detect covariancebased network-like spatial components [Source Based Morphometry (SBM)] was performed to analyze the GMV. Paired t tests were used to study changes in the loading coefficients of GMV in the spatial components between two time points. The reduction in PANSS scores between the baseline (T0) and 1-year follow-up (T1) expressed as a ratio of the baseline scores (reduction ratio) was computed for positive, negative, and disorganization symptoms. Separate multiple regression analyses were conducted to predict the longitudinal change in symptoms (treatment response) using the loading coefficients of spatial components that differed between T0 and T1 with age, gender, duration of illness, and antipsychotic dose as covariates. We also tested the putative "toxicity" effects of baseline symptom severity on the GMV at 1 year using multiple regression analysis. Results: Of the 30 spatial components of gray matter extracted using SBM, loading coefficients of anterior cingulate cortex (ACC), insula and inferior frontal gyrus (IFG), superior temporal gyrus (STG), middle temporal gyrus (MTG), precuenus, and dorsolateral prefrontal cortex (DLPFC) reduced with time in patients. Specifically, the lower volume of insula and IFG at baseline predicted a lack of improvement in positive and disorganization symptoms. None of the symptom severity scores (positive, negative, or disorganization) at baseline independently predicted the reduced GMV at 1 year. Conclusions: The baseline deficit in a covariance-based network-like spatial component comprising of insula and IFG is predictive of the clinical course of schizophrenia. We do not find any evidence to support the notion of symptoms per se being neurotoxic to gray matter tissue. If judiciously combined with other available predictors of clinical outcome, multivariate morphometric information can improve our ability to predict prognosis in schizophrenia.

Improving the predictive potential of diffusion MRI in schizophrenia using normative models-Towards subject-level classification

Structural Covariance of Depth-Dependent Intracortical Myelination in the Human Brain and Its Application to Drug-Naive Schizophrenia: a T1w/T2w MRI Study

Prognostic Utility of Multivariate Morphometry in Schizophrenia.

Two Patterns of White Matter Abnormalities in Medication-Naive Patients With First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging and Cluster Analysis.

Elucidating the Relationship Between White Matter Structure, Demographic, and Clinical Variables in Schizophrenia—a Multicenter Harmonized Diffusion Tensor Imaging Study

Using normative modeling to assess pharmacological treatment effect on brain state in patients with schizophrenia

Multiscale heterogeneity of white matter morphometry in psychiatric disorders

Classification of First-Episode Schizophrenia Using Multimodal Brain Features: A Combined Structural and Diffusion Imaging Study

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group

Detecting Schizophrenia at the Level of the Individual: Relative Diagnostic Value of Whole-Brain Images, Connectome-Wide Functional Connectivity and Graph-Based Metrics

Diffusion Magnetic Resonance Imaging Study of Schizophrenia in the Context of Abnormal Neurodevelopment Using Multiple Site Data in a Chinese Han Population.

Subcortical Brain Volume Abnormalities in 2028 Individuals with Schizophrenia and 2540 Healthy Controls Via the ENIGMA Consortium

Lifespan Normative Models of White Matter Fractional Anisotropy: Applications to Early Psychosis

Lifespan Normative Modeling of Brain Microstructure

Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk

White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study

Consistent brain structural abnormalities and multisite individualised classification of schizophrenia using deep neural networks

A normative modeling approach to quantify white matter changes and predict functional outcomes in stroke patients

Predicting Individualized Clinical Measures by a Generalized Prediction Framework and Multimodal Fusion of MRI Data.

Support Vector Machine-Based Classification of First Episode Drug-Naïve Schizophrenia Patients and Healthy Controls Using Structural MRI.

Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study.